drugset / Trial / NCT07475390
99mTc-1-thio-D-glucose SPECT/CT Versus 18F-Fluoroethyl-l-tyrosine PET/CT in Brain Tumor Imaging
Active not recruiting
40 enrolled
Tomsk National Research Medical Center of the Russian Academy of Sciences
NaSingle-groupOpen-labelDiagnostic
Summary
An open-label, single-center study with 99mTc-1-thio-D-glucose single photon emission computed tomography / computed tomography (SPECT/CT) and 18F-fluoroethyl-l-tyrosine (18F-FET) positron emission tomography / computed tomography (PET/CT) in primary and recurrent glioma patients, where the primary endpoint of the study is to compare imaging properties of 99mTc-1-thio-D-glucose SPECT/CT and 18F-FET PET/CT of brain tumor Imaging.
Timeline
- Start
- 2026-02-15
- Primary completion
- 2027-12-31
- Completion
- 2028-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FET | Diagnostic / imaging agent | — | — |
| Subject | 99mTc-1-thio-D-glucose | Diagnostic / imaging agent | — | — |